Cargando…
Proinsulin-mediated induction of type 1 diabetes in HLA-DR4-transgenic mice
Antigen-specific immunotherapy of autoimmune disease currently remains the only potentially curative approach. However, translation of promising pre-clinical results into successful clinical application has proven challenging. In part, this is because pre-clinical findings in mouse models have to be...
Autores principales: | Verhagen, Johan, Smith, Emma L., Whettlock, Emily M., Macintyre, Benedict, Peakman, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148278/ https://www.ncbi.nlm.nih.gov/pubmed/30237494 http://dx.doi.org/10.1038/s41598-018-32546-4 |
Ejemplares similares
-
Proinsulin peptide promotes autoimmune diabetes in a novel HLA-DR3-DQ2-transgenic murine model of spontaneous disease
por: Verhagen, Johan, et al.
Publicado: (2019) -
Production of recombinant human proinsulin in the milk of transgenic mice
por: Qian, Xi, et al.
Publicado: (2014) -
Recognition of Human Proinsulin Leader Sequence by Class I–Restricted T-Cells in HLA-A*0201 Transgenic Mice and in Human Type 1 Diabetes
por: Toma, Andréa, et al.
Publicado: (2009) -
Tolerance to Proinsulin-1 Reduces Autoimmune Diabetes in NOD Mice
por: Jhala, Gaurang, et al.
Publicado: (2021) -
HLA-DR7 and HLA-DQ2: Transgenic mouse strains tested as a model system for ximelagatran hepatotoxicity
por: Lundgren, Hanna, et al.
Publicado: (2017)